Log in to save to my catalogue

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Pr...

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Pr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8500569

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study

About this item

Full title

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study

Publisher

United States: Wolters Kluwer

Journal title

Clinical and translational gastroenterology, 2021-10, Vol.12 (10), p.e00414-e00414

Language

English

Formats

Publication information

Publisher

United States: Wolters Kluwer

More information

Scope and Contents

Contents

To report the prevalence and outcomes of unselected pancreatic cancer (PC) patients with pathogenic/likely pathogenic germline variants (PGVs) detected using a universal testing approach.
We undertook a prospective, multisite study of germline sequencing using a >80 gene next-generation sequencing platform among 250 patients with PC (not selecte...

Alternative Titles

Full title

Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8500569

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8500569

Other Identifiers

ISSN

2155-384X

E-ISSN

2155-384X

DOI

10.14309/ctg.0000000000000414

How to access this item